| MKGAF Stock | | | USD 149.50 1.71 1.13% |
Executive
Dr. Kai Beckmann is Chief Executive Officer Performance Materials, Member of the Executive Board of MERCK Kommanditgesellschaft auf Aktien since 2017. He is responsible for the Performance Materials business sector, which he was leading as CEO since September 2017. In October 2018, Kai Beckmann took also over the responsibility for the Darmstadt site and Inhouse Consulting. In addition, he acts as Country Speaker Germany with responsibility for codetermination matters. Prior to his current role, Kai Beckmann was Chief Administration Officer of Merck with responsibility for Group Human Resources, Group Business Technology, Group Procurement, Inhouse Consulting, Site Operations and Merck Business Services as well as Environment, Health, Safety, Security, Quality. In 2007, he became the first CIO of Merck, with responsibility for Corporationrationrate Information Services. From 2004 to 2007, he served as Managing Director of the Merck companies in Singapore and Malaysia, and prior to that he held senior executive responsibility for the Information Management and Consulting unit from 1999 to 2004. He began his career at Merck in 1989 as an IT system consultant. since 2017.
| Age | 58 |
| Tenure | 7 years |
| Phone | 49 6151 72 0 |
| Web | https://www.merckgroup.com |
MERCK Kommanditgesells Management Efficiency
The company has return on total asset
(ROA) of
0.0656 % which means that it generated a profit of $0.0656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1422 %, meaning that it generated $0.1422 on every $100 dollars invested by stockholders. MERCK Kommanditgesells' management efficiency ratios could be used to measure how well MERCK Kommanditgesells manages its routine affairs as well as how well it operates its assets and liabilities.
MERCK Kommanditgesellschaft auf has accumulated 7.93
B in total debt with debt to equity ratio
(D/E) of 0.45, which is about average as compared to similar companies. MERCK Kommanditgesells has a current ratio of 1.25, suggesting that it
may not be capable to disburse its financial obligations in time and when they become due. Debt can assist MERCK Kommanditgesells until it has trouble settling it off, either with new capital or with free cash flow. So, MERCK Kommanditgesells' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MERCK Kommanditgesells sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MERCK to invest in growth at high rates of return. When we think about MERCK Kommanditgesells' use of debt, we should always consider it together with cash and equity.
Similar Executives
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kgaa operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 62770 people. MERCK Kommanditgesellschaft auf [MKGAF] is a
Pink Sheet which is traded between brokers as part of OTC trading.
Management Performance
MERCK Kommanditgesells Leadership Team
Elected by the shareholders, the MERCK Kommanditgesells' board of directors comprises two types of representatives: MERCK Kommanditgesells inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MERCK. The board's role is to monitor MERCK Kommanditgesells' management team and ensure that shareholders' interests are well served. MERCK Kommanditgesells' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MERCK Kommanditgesells' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthias Heinzel, CEO Board | |
| Peter Guenter, CEO Board | |
| Barbara Weiland, Chief Officer | |
| Dirk Toepfer, Chief Officer | |
| Gerhard Schmitz, Head Accounting | |
| Belen MD, Chair CEO | |
| Kai Beckmann, Head of Group HR, General Partner and Member of Executive Board | |
| Marcus Kuhnert, Group CFO and Member of Executive Board | |
| Constantin Fest, Head of Investor Relations | |
| Friederike Rotsch, Group Compliance | |
MERCK Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is MERCK Kommanditgesells a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in MERCK Pink Sheet
MERCK Kommanditgesells financial ratios help investors to determine whether MERCK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MERCK with respect to the benefits of owning MERCK Kommanditgesells security.